Press release
Osteoporosis Pipeline Drugs in 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, and Route of Administration by DelveInsight Featuring Novadip, Eli Lilly, Teva Pharmaceuticals, Novartis, Amgen, USB, Gedeon Richter Plc., Luye Pharma
Osteoporosis Pipeline
Uncover the Current Osteoporosis Clinical Development Scenario and Growth Prospects across the Osteoporosis Market through the lens of DelveInsight's "Osteoporosis Pipeline Insight, 2023" report. This report not only delivers in-depth commercial and clinical assessments but also spans the entire developmental spectrum, from pre-clinical phases to the marketed phase.
Dive into detailed descriptions of each drug, encompassing their mechanisms of action, clinical studies, NDA approvals (if any), and a comprehensive overview of product development activities. The report goes beyond, exploring technological aspects, collaborations, mergers and acquisitions, funding details, designations, and other crucial product-related information. Stay ahead with DelveInsight's unparalleled insights into the dynamic Osteoporosis Pipeline.
Some of the key takeaways from the Osteoporosis Pipeline Report: https://www.delveinsight.com/sample-request/osteoporosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Companies across the globe are diligently working toward developing novel Osteoporosis treatment therapies with a considerable amount of success over the years.
• Osteoporosis companies working in the treatment market are Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Entera Bio, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, Novartis, Amgen/USB, Gedeon Richter Plc., Luye Pharma, Haoma Medica, and others, are developing therapies for the Osteoporosis treatment
• Emerging Osteoporosis therapies in the different phases of clinical trials are- Research programme, RT-102, SHR-1222, EB613, VOLT01, CT-P41, TVB-009, Zoledronic Acid, Romosozumab, RGB-14-P, Denosumab biosimilar, NaQuinate, and others are expected to have a significant impact on the Osteoporosis market in the coming years.
• The "A Randomised, Double-Blind, Multinational, Multicenter Study to Compare Efficacy, Safety, and Immunogenicity of TVB-009P and Denosumab (Prolia®) in Patients With Postmenopausal Osteoporosis" was started by Teva Pharmaceuticals in March 2023.
Osteoporosis Overview
Osteoporosis is a condition in which the density of bone decreases, weakening it and making it more brittle. Osteoporosis causes bone to become deformable and unusually porous, much like a sponge. This skeletal condition makes the bones weaker and makes them more prone to fractures (breaks).
Get a Free Sample PDF Report to know more about Osteoporosis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/osteoporosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Emerging Osteoporosis Drugs Under Different Phases of Clinical Development Include:
• Research programme: Lactocore
• RT-102: Rani Therapeutics
• SHR-1222: Jiangsu HengRui Medicine
• EB613: Entera Bio
• VOLT01: Levolta Pharmaceuticals, Inc.
• CT-P41: Celltrion
• TVB-009: Teva Pharmaceuticals
• Zoledronic Acid: Novartis
• Romosozumab: Amgen/USB
• RGB-14-P: Gedeon Richter Plc.
• Denosumab biosimilar: Luye Pharma
• NaQuinate: Haoma Medica
• JMT 103: Shanghai JMT-Bio Inc.
• TST-002: Transcenta Holding
Osteoporosis Route of Administration
Osteoporosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Osteoporosis Molecule Type
Osteoporosis Products have been categorized under various Molecule types, such as
• Oligonucleotide
• Peptide
• Small molecule
Osteoporosis Pipeline Therapeutics Assessment
• Osteoporosis Assessment by Product Type
• Osteoporosis By Stage and Product Type
• Osteoporosis Assessment by Route of Administration
• Osteoporosis By Stage and Route of Administration
• Osteoporosis Assessment by Molecule Type
• Osteoporosis by Stage and Molecule Type
DelveInsight's Osteoporosis Report covers around 40+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Osteoporosis product details are provided in the report. Download the Osteoporosis pipeline report to learn more about the emerging Osteoporosis therapies at:
https://www.delveinsight.com/sample-request/osteoporosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key companies in the Osteoporosis Therapeutics Market include:
Key companies developing therapies for Osteoporosis are - Shanghai Biomabs Pharmaceutical, Angitia Biopharmaceuticals, Dongkook pharmaceutical, Biocon Biologics UK Ltd, Bonus BioGroup Ltd., Cellatoz Therapeutics, Inc., Keros Therapeutics, Clayton Biotechnologies, Novadip, Eli Lilly, Teva Pharmaceuticals, Novartis, Amgen, USB, Gedeon Richter Plc., Luye Pharma, Haoma Medica, Jiangsu HengRui Medicine, Shanghai JMT-Bio Inc., Transcenta Holding, Celltrion, Enzene Biosciences, Fresenius Kabi, Gedeon Richter, Samsung Bioepis, Alvotech, MAbxience, Shanghai Henlius Biotech, Rani therapeutics, Entera Bio, Paras Biopharmaceuticals, Shenzhen Salubris Pharmaceutical, Enteris Biopharma, Prestige Biopharma, Shinpoong Ltd., and others.
Osteoporosis Pipeline Analysis:
The Osteoporosis pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Osteoporosis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Osteoporosis Treatment.
• Osteoporosis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Osteoporosis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Osteoporosis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Osteoporosis drugs and therapies-
https://www.delveinsight.com/sample-request/osteoporosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Osteoporosis Pipeline Market Drivers
Rising geriatric population prone to low bone density, growing investments in research and development, increased Focus on development of biosimilars for the treatment of Osteoporosis are some of the important factors that are fueling the Osteoporosis Market.
Osteoporosis Pipeline Market Barriers
• However, side effects and complications associated with osteoporosis drugs, patent expiration of osteoporosis drugs and other factors are creating obstacles in the Osteoporosis Market growth.
Scope of Osteoporosis Pipeline Drug Insight
• Coverage: Global
• Key Osteoporosis Companies: Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Entera Bio, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, Novartis, Amgen/USB, Gedeon Richter Plc., Luye Pharma, Haoma Medica, and others
• Key Osteoporosis Therapies: Research programme, RT-102, SHR-1222, EB613, VOLT01, CT-P41, TVB-009, Zoledronic Acid, Romosozumab, RGB-14-P, Denosumab biosimilar, NaQuinate, and others
• Osteoporosis Therapeutic Assessment: Osteoporosis current marketed and Osteoporosis emerging therapies
• Osteoporosis Market Dynamics: Osteoporosis market drivers and Osteoporosis market barriers
Request for Sample PDF Report for Osteoporosis Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/osteoporosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Osteoporosis Report Introduction
2. Osteoporosis Executive Summary
3. Osteoporosis Overview
4. Osteoporosis- Analytical Perspective In-depth Commercial Assessment
5. Osteoporosis Pipeline Therapeutics
6. Osteoporosis Late Stage Products (Phase II/III)
7. Osteoporosis Mid Stage Products (Phase II)
8. Osteoporosis Early Stage Products (Phase I)
9. Osteoporosis Preclinical Stage Products
10. Osteoporosis Therapeutics Assessment
11. Osteoporosis Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Osteoporosis Key Companies
14. Osteoporosis Key Products
15. Osteoporosis Unmet Needs
16 . Osteoporosis Market Drivers and Barriers
17. Osteoporosis Future Perspectives and Conclusion
18. Osteoporosis Analyst Views
19. Appendix
20. About DelveInsight
Latest Reports launched by DelveInsight:
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Hepatitis B Virus Market: https://www.delveinsight.com/infographics/chronic-hepatitis-b-virus-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Alopecia Aerata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Brain/cranial Implants Market: https://www.delveinsight.com/report-store/brain-implants-market-market
• Global Electrophysiology Devices Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Scleroderma Market: https://www.delveinsight.com/report-store/scleroderma-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Hyperuricemia Market: https://www.delveinsight.com/report-store/hyperuricemia-pipeline-insight
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
Contact Us:
Ankit Nigam
Assistant Manager Marketing
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoporosis Pipeline Drugs in 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, and Route of Administration by DelveInsight Featuring Novadip, Eli Lilly, Teva Pharmaceuticals, Novartis, Amgen, USB, Gedeon Richter Plc., Luye Pharma here
News-ID: 3350097 • Views: …
More Releases from DelveInsight Business Research
Psilocybin Market Size for Anorexia Nervosa expected to increase at a decent pac …
[Albany, United States] Latest report, Psilocybin Market Size, Forecast, and Drug Insight - 2032 is published by DelveInsight, a leader in healthcare research firm, providing insights into the Psilocybin market landscape and market forecast of Psilocybin up to 2032. This report is now available for review and analysis.
Are you interested in finding out the projected market size of Psilocybin in 2032? Click @ Psilocybin Market Size - https://www.delveinsight.com/report-store/psilocybin-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Psilocybin Market…
Migraine Market to Exhibit Rapid Growth Rate During the Forecast Period (2024-20 …
The Migraine market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Migraine pipeline products will significantly revolutionize the Migraine market dynamics.
DelveInsight's "Migraine Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Migraine, historical and forecasted epidemiology as well as the Migraine market trends in the United States, EU4 (Germany, Spain, Italy, France)…
Severe Asthma Market Forecast by 2034: Epidemiology Analysis, Emerging Therapies …
DelveInsight's "Severe Asthma Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Severe Asthma, historical and forecasted epidemiology as well as the Severe Asthma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Severe Asthma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Severe Asthma Market Forecast
https://www.delveinsight.com/sample-request/severe-asthma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Inflammation and Pain Post Cataract Surgery Market to Witness Upsurge in Growth …
DelveInsight's "Inflammation and Pain Post Cataract Surgery Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Inflammation and Pain Post Cataract Surgery, historical and forecasted epidemiology as well as the Inflammation and Pain Post Cataract Surgery market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Inflammation and Pain Post Cataract Surgery market outlook,…
More Releases for Osteoporosis
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging populati …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Bone Densitometry Scan for Osteoporosis & Osteopenia
Global Bone Densitometers Market: Snapshot
Of late, the global bone densitometers market has been registering a phenomenal increase in its size and valuation. The significant rise in the pool of patients suffering from arthritis and vitamin D deficiency, supported by the surge in the geriatric population across the world, have influenced this market substantially. The increasing prevalence of osteoporosis in post-menopausal women is also contributing considerably to the growth of…
2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022
The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%.
Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone…
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews
February 03, 2017
Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
